ResMed AirSense 11 CPAP machine

ResMed is a pioneer in the sleep technology industry, founded in 1989 in Australia by Peter Farrell to commercialize a treatment for obstructive sleep apnea. The AirSense 11 series represents their latest generation of CPAP (Continuous Positive Airway Pressure) devices, designed to improve patient outcomes through digital connectivity and personalized support.

While the company has its roots in Australia, it has grown into a global leader in respiratory medicine. Today, ResMed operates with a highly decentralized manufacturing and distribution network. While much of the sophisticated production occurs in Singapore and Australia, the company serves patients in over 140 countries.

ResMed Inc. is a publicly traded company listed on both the New York Stock Exchange (NYSE) and the Australian Securities Exchange (ASX), with its corporate headquarters located in San Diego, California, USA. This evolution marks its transition from a regional Australian startup to a global medical technology powerhouse.